PP
PFE icon

Pacifica Partners’s Pfizer PFE Stock Holding History

Pacifica Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.75K Hold
154
– – ﹤0.01% 363
2026
Q1 		$4.32K Hold
154
– – ﹤0.01% 364
2025
Q4 		$3.88K Hold
154
– – ﹤0.01% 352
2025
Q3 		$4.19K Sell
154
-85
-36% -$2.1K ﹤0.01% 400
2025
Q2 		$5.78K Sell
239
-535
-69% -$12.5K ﹤0.01% 382
2025
Q1 		$18.8K Buy
774
+8
+1% +$209 0.01% 286
2024
Q4 		$20.4K Sell
766
-4,016
-84% -$109K 0.01% 282
2024
Q3 		$138K Sell
4,782
-118
-2% -$3.44K 0.06% 130
2024
Q2 		$136K Buy
4,900
+252
+5% +$6.94K 0.06% 133
2024
Q1 		$127K Sell
4,648
-216
-4% -$5.99K 0.06% 132
2023
Q4 		$141K Buy
4,864
+337
+7% +$10.2K 0.07% 121
2023
Q3 		$152K Buy
4,527
+1,750
+63% +$61.9K 0.08% 111
2023
Q2 		$101K Buy
2,777
+5
+0.2% +$195 0.06% 124
2023
Q1 		$115K Buy
2,772
+170
+7% +$7.34K 0.07% 117
2022
Q4 		$133K Buy
2,602
+132
+5% +$6.33K 0.09% 104
2022
Q3 		$110K Hold
2,470
– – 0.08% 115
2022
Q2 		$127K Buy
2,470
+8
+0.3% +$408 0.09% 115
2022
Q1 		$117K Hold
2,462
– – 0.08% 120
2021
Q4 		$138K Buy
2,462
+3
+0.1% +$149 0.09% 111
2021
Q3 		$108K Buy
2,459
+4
+0.2% +$177 0.08% 111
2021
Q2 		$96K Buy
2,455
+5
+0.2% +$194 0.07% 111
2021
Q1 		$88K Buy
2,450
+5
+0.2% +$178 0.07% 108
2020
Q4 		$92K Sell
2,445
-128
-5% -$4.7K 0.09% 96
2020
Q3 		$90K Buy
2,573
+4
+0.2% +$140 0.1% 89
2020
Q2 		$84K Buy
2,569
+331
+15% +$11.2K 0.09% 93
2020
Q1 		$71K Sell
2,238
-105
-4% -$3.58K 0.09% 105
2019
Q4 		$87K Buy
+2,343
New +$83.5K 0.08% 106

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WG
Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

Pacifica Partners's PFE Position: Q2 2026 in Review

Pacifica Partners held its Pfizer (PFE) position steady in Q2 2026 at 154 shares worth $3.75K. The position accounts for ﹤0.01% of the portfolio, ranked #363.

Pacifica Partners first reported a position in PFE in Q4 2019 and has held it in 27 quarters since. The position peaked at $152K in Q3 2023. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Pacifica Partners held 154 shares of Pfizer worth $3.75K as of Q2 2026.
  • Pacifica Partners left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up ﹤0.01% of Pacifica Partners's portfolio in Q2 2026, its #363 holding.
  • Pacifica Partners first reported a position in Pfizer in Q4 2019 and has held it in 27 quarters since.
  • Pacifica Partners's Pfizer position peaked at $152K in Q3 2023.
  • 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Pacifica Partners's 13F filing for Q2 2026, filed 13 Jul 2026.